Carregant...
Molecular subtyping of leiomyosarcoma with 3′ end RNA sequencing
Leiomyosarcoma (LMS) is a malignant neoplasm with smooth muscle differentiation. Little is known about its molecular heterogeneity and no targeted therapy currently exists for LMS. We performed expression profiling on 99 cases of LMS with 3′ end RNA sequencing (3SEQ) and demonstrated the existence o...
Guardat en:
| Publicat a: | Genom Data |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4521214/ https://ncbi.nlm.nih.gov/pubmed/26240788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gdata.2015.06.029 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|